Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Communications Biology|December 17, 2025
Integrated analysis of post-transcriptional regulations reveals insights into acute myeloid leukemiaElissa Khadra, Zoaila Iqbal, Morgane Le Gall, et al.Oncotarget|April 24, 2018
Prognostic value of early 18F-FDG PET scanning evaluation in immunocompetent primary CNS lymphoma patientsRudy Birsen, Estelle Blanc, Lise Willems, et al.Cell Reports|May 26, 2015
Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid LeukemiaPierre Sujobert, Laury Poulain, Etienne Paubelle, et al.Science Advances|November 25, 2015
Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemiaAlexa S Green, Thiago T Maciel, Marie-Anne Hospital, et al.Science Translational Medicine|October 7, 2016
Homoharringtonine (omacetaxine mepesuccinate) as an adjunct for FLT3-ITD acute myeloid leukemiaStephen S Y Lam, Eric S K Ho, Bai-Liang He, et al.Oncotarget|April 24, 2018
A novel, dual pan-PIM/FLT3 inhibitor SEL24 exhibits broad therapeutic potential in acute myeloid leukemiaWojciech Czardybon, Renata Windak, Aniela Gołas, et al.Nature Medicine|December 9, 2014
Mutations in G protein β subunits promote transformation and kinase inhibitor resistanceAkinori Yoda, Guillaume Adelmant, Jerome Tamburini, et al.Leukemia|March 31, 2022
RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemiaJustine Decroocq, Rudy Birsen, Camille Montersino, et al.Leukemia|August 26, 2024
Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturationVilma Dembitz, Hannah Lawson, Richard Burt, et al.Cancer Discovery|April 3, 2023
C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress-Induced Ferroptosis in FLT3-Mutant LeukemiaMarie Sabatier, Rudy Birsen, Laura Lauture, et al.Pageof 5